Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2012 Aug 1.

Published in final edited form as: Cancer. 2011 Jan 24;117(15):3493–3501. doi: 10.1002/cncr.25887

Age at diagnosis is prognostic of outcome in RMS. Infants have poorer FFS than older patients with RMS. (A) Estimated 5-year FFS (95% CI) by age group are 57% (44%,67%) for age < 1 year, 81% (79%,93%) for age 1–9 years, and 68% (63%,72%) for age ≥ 10 years (p-value < 0.001). (B) Estimated 5-year OS (95% CI) are 76% (65%,85%) for age < 1 year, 87% (85%, 89%) for age 1–9 years, and 75% (71%–79%) for age ≥ 10 years (p-value < 0.001).

Age at diagnosis is prognostic of outcome in RMS. Infants have poorer FFS than older patients with RMS. (A) Estimated 5-year FFS (95% CI) by age group are 57% (44%,67%) for age < 1 year, 81% (79%,93%) for age 1–9 years, and 68% (63%,72%) for age ≥ 10 years (p-value < 0.001). (B) Estimated 5-year OS (95% CI) are 76% (65%,85%) for age < 1 year, 87% (85%, 89%) for age 1–9 years, and 75% (71%–79%) for age ≥ 10 years (p-value < 0.001).